共 41 条
- [1] Liver toxicity of rosuvastatin therapy[J]. Giuseppe Famularo,Luca Miele,Giovanni Minisola,Antonio Grieco.World Journal of Gastroenterology. 2007(08)
- [2] Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks[J] . C. Michael Minder,Roger S. Blumenthal,Michael J. Blaha.Current Opinion in Cardiology . 2013 (5)
- [3] Long-term Clinical Outcomes of Statin Use for Chronic Heart Failure: A Meta-analysis of 15 Prospective Studies[J] . Jian-Qiang Wang,Guo-Rong Wu,Zheng Wang,Xiao-Ping Dai,Xiang-Rong Li.Heart, Lung and Circulation . 2013
- [4] Protective effects of l -carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin[J] . Rute A.P. Costa,Mariana P. Fernandes,Nadja C. de Souza-Pinto,Aníbal E. Vercesi.European Journal of Pharmacology . 2013 (1-3)
- [5] Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2012, 590 (24): : 6389 - 6402
- [6] Nitric oxide prevents atorvastatin‐induced skeletal muscle dysfunction and alterations in mice[J] . Giuseppe D’Antona,Anna Mascaro,Angela Monopoli,Daniela Miglietta,Ennio Ongini,Roberto Bottinelli.Muscle Nerve . 2012 (1)
- [7] Statins are diabetogenic – Myth or reality?[J] . Naveed Sattar,Marja-Riitta Taskinen.Atherosclerosis (Supplements) (Component) . 2012 (1)
- [8] Statin induced myotoxicity [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (04) : 317 - 324
- [10] Statins in Heart Failure: The Paradox Between Large Randomized Clinical Trials and Real Life[J] . Paloma Gastelurrutia,Josep Lupón,Marta de Antonio,Agustin Urrutia,Crisanto Díez,Ramón Coll,Salvador Altimir,Antoni Bayes-Genis.Mayo Clinic Proceedings . 2012 (6)